← Leaderboards
Yan Shu
University Of Maryland Baltimore
$4,220,804
Attributed
$5,808,783
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,808,783 · 4
By mechanism
R01$4,582,866 · 3
U01$1,225,917 · 1
Top collaborators
- Fengtian Xue3 shared
- Allison Dunn2 shared
- Irina Timofte2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Abraham Schneider$2,695,113
- Fengtian Xue$2,809,086
- Kathleen A Griffith$219,718
- Irina Timofte$408,639
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPathway InteractionsCellsPharmacotherapyRegulationAffectMolecularResponseIn VitroMediatingMembraneTransmembrane TransportTraffickingUptakeProtein TransportCarrier ProteinsCell ModelProteinsVariantTissuesMetabolicMouse ModelDiabetes MellitusIncidence
Grant awards (14)
Pharmacokinetics (PK) and Pharmacodynamics (PD) Characterization of mTOR Inhibitors in Older Adults$607,516
U01 · FY2025 · AG
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis$485,056
R01 · FY2025 · DK · contact PI
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney$363,710
R01 · FY2025 · ES · contact PI
Pharmacokinetics (PK) and Pharmacodynamics (PD) Characterization of mTOR Inhibitors in Older Adults$618,401
U01 · FY2024 · AG
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis$517,394
R01 · FY2024 · DK · contact PI
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney$363,710
R01 · FY2024 · ES · contact PI
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis$538,952
R01 · FY2023 · DK · contact PI
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney$363,710
R01 · FY2023 · ES · contact PI
Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney$363,708
R01 · FY2022 · ES · contact PI
Xenobiotic Transporter Regulation and IRIP Function$315,200
R01 · FY2016 · GM · contact PI
Xenobiotic Transporter Regulation and IRIP Function$315,200
R01 · FY2015 · GM · contact PI
Xenobiotic Transporter Regulation and IRIP Function$315,200
R01 · FY2014 · GM · contact PI
Xenobiotic Transporter Regulation and IRIP Function$304,168
R01 · FY2013 · GM · contact PI
Xenobiotic Transporter Regulation and IRIP Function$336,858
R01 · FY2012 · GM · contact PI